OA
BIO icon

OFI Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

OFI Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$361K Buy
2,685
+26
+1% +$3.74K 0.02% 897
2015
Q2 		$400K Sell
2,659
-223
-8% -$31.9K 0.02% 890
2015
Q1 		$390K Buy
2,882
+27
+0.9% +$3.35K 0.02% 897
2014
Q4 		$344K Sell
2,855
-265
-8% -$30.5K 0.02% 927
2014
Q3 		$354K Buy
3,120
+170
+6% +$20.1K 0.03% 832
2014
Q2 		$353K Buy
2,950
+464
+19% +$56.7K 0.03% 854
2014
Q1 		$319K Buy
2,486
+235
+10% +$30.1K 0.02% 853
2013
Q4 		$278K Buy
2,251
+189
+9% +$23K 0.02% 909
2013
Q3 		$242K Buy
2,062
+66
+3% +$7.78K 0.02% 857
2013
Q2 		$224K Buy
+1,996
New +$234K 0.02% 813

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OFI Advisors's BIO Position: Q3 2015 in Review

OFI Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 0.98% in Q3 2015, buying an estimated $3.74K and bringing the position to 2,685 shares worth $361K. The position accounts for 0.02% of the portfolio, ranked #897.

OFI Advisors first reported a position in BIO in Q2 2013 and has held it in 10 quarters since. The position peaked at $400K in Q2 2015. 244 funds tracked by Wall St. Rank hold BIO as of Q3 2015.

  • OFI Advisors held 2,685 shares of Bio-Rad Laboratories Class A worth $361K as of Q3 2015.
  • OFI Advisors bought 26 Bio-Rad Laboratories Class A shares in Q3 2015, an estimated $3.74K.
  • Bio-Rad Laboratories Class A made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #897 holding.
  • OFI Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Bio-Rad Laboratories Class A position peaked at $400K in Q2 2015.
  • 244 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.